IBB icon

iShares Biotechnology ETF
IBB

Overview Fund Activity

419 hedge funds and large institutions have $6.6B invested in iShares Biotechnology ETF in 2015 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 134 increasing their positions, 150 reducing their positions, and 38 closing their positions.

Holders
419
Holders Change
+20
Holders Change %
+5.01%
% of All Funds
11.3%
Holding in Top 10
42
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+27.27%
% of All Funds
1.13%
New
65
Increased
134
Reduced
150
Closed
38
Calls
$665M
Puts
$1.9B
Net Calls
-$1.23B
Net Calls Change
-$621M

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$85.4M
2
Citigroup
2
Citigroup
New York
$600M
3
Millennium Management
3
Millennium Management
New York
$54.6M
4
SG Americas Securities
4
SG Americas Securities
New York
$116M
5
MAA
5
Managed Account Advisors
New Jersey
$189M

Top Sellers

1
BFA
1
Beaumont Financial Advisors
Massachusetts
$8.3M
2
Bank of America
2
Bank of America
North Carolina
$417M
3
Goldman Sachs
3
Goldman Sachs
New York
$968M
4
Morgan Stanley
4
Morgan Stanley
New York
$683M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$512M
Name Market Value Shares Shares
Change 		Shares
Change %
MIG
476
Mariner Investment Group
New York
– – – –
WCM
477
Wildcat Capital Management
New York
– – – –
HP
478
Holowesko Partners
Bahamas
– – – –
JT
479
Jump Trading
Illinois
– – – –
GAMA
480
Graticule Asia Macro Advisors
New York
– – – –
PCM
481
Pyrrho Capital Management
New York
– – – –
SPM
482
Symmetry Peak Management
Pennsylvania
– – – –
SAM
483
Serengeti Asset Management
New York
– – – –
PCM
484
Prelude Capital Management
New York
– – – –
16 17 18 19
20